Bradda Head  Lithium exceeds targets, secures US$3 million royalty and moves closer to production. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLegal & General Regulatory News (LGEN)

Share Price Information for Legal & General (LGEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 233.40
Bid: 233.80
Ask: 233.90
Change: 2.60 (1.13%)
Spread: 0.10 (0.043%)
Open: 231.70
High: 234.30
Low: 231.70
Prev. Close: 230.80
LGEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

6 Dec 2017 18:06

RNS Number : 6225Y
Faron Pharmaceuticals Oy
06 December 2017
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Faron Pharmaceuticals Oy7437009H31TO1DC0EB42

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

X

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii: Disclosure as per company's Articles of Association

X

3. Details of person subject to the notification obligationiv

Name

 

Legal & General Group Plc (Group)

 

Legal & General Investment Management Limited (LGIM)

 

City and country of registered office (if applicable)

1 Coleman St, London EC2R 5AA

4. Full name of shareholder(s) (if different from 3.)v

Name

Legal & General Assurance Society (LGAS)

 

City and country of registered office (if applicable)

1 Coleman St, London EC2R 5AA

5. Date on which the threshold was crossed or reachedvi:

22 November 2017

6. Date on which issuer notified (DD/MM/YYYY):

 

23 November 2017

 

 

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

4.68%

-

4.68%

 

29,164,544

 

Position of previous notification (if

applicable)

5.19%

-

5.19%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

ORD NPV

1,365,000

4.68%

SUBTOTAL 8. A

1,365,000

4.68%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

 

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

 

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

x

 

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

Legal & General Group (Direct/Indirect)

4.68%

4.68%

 

Legal & General Investment Management (Holdings) Limited

(Direct/Indirect)

4.68%

4.68%

 

Legal & General Assurance Society (Direct)

0.66%

0.66%

 

 

Legal & General Group (Direct/Indirect)

4.68%

4.68%

 

Legal & General Investment Management (Holdings) Limited

(Direct/Indirect)

4.68%

4.68%

Legal & General Assurance (Pensions Management) Limited

(Direct)

-

-

Legal & General Group (Direct/Indirect)

4.68%

4.68%

Legal & General Investment Management (Holdings) Limited

(Direct/Indirect)

4.68%

4.68%

Legal & General Investment Management Limited (Indirect)

4.68%

4.68%

Legal & General Group (Direct/Indirect)

4.68%

4.68%

Legal & General Investment Management (Holdings) Limited

(Direct/Indirect)

4.68%

4.68%

Legal & General (Unit Trust Managers) Limited (Indirect)

4.01%

4.01%

 

 

 

 

 

 

10. In case of proxy voting, please identify:

 

Name of the proxy holder

N/A

 

The number and % of voting rights held

N/A

 

The date until which the voting rights will be held

N/A

 

 

 

 

11. Additional informationxvi

 

 

Notification using the total voting rights figure of 29,164,544

 

 

Place of completion

Brunel House, 2 Fitzalan Road, Cardiff, CF24 0EB

Date of completion

22/11/2017

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLGMMGZRVGGNZM
Date   Source Headline
3rd Jan 20235:00 pmRNSDirector/PDMR Shareholding
3rd Jan 20235:00 pmRNSDirector/PDMR Shareholding
3rd Jan 20235:00 pmRNSBlock listing Interim Review
22nd Dec 20225:00 pmRNSDirector/PDMR Shareholding
2nd Dec 20225:00 pmRNSDirector/PDMR Shareholding
1st Dec 20225:00 pmRNSDirector/PDMR Shareholding
1st Dec 20225:00 pmRNSDirector/PDMR Shareholding
1st Dec 20225:00 pmRNSTotal Voting Rights
29th Nov 20221:50 pmRNSIFRS 17 investor and analyst event
18th Nov 20227:00 amRNSTrading Statement
11th Nov 20229:00 amRNSBoard Committee Appointment
7th Nov 20224:31 pmRNSHolding(s) in Company
2nd Nov 20225:00 pmRNSDirector/PDMR Shareholding
1st Nov 20225:33 pmRNSDirector/PDMR Shareholding
1st Nov 20225:31 pmRNSDirector/PDMR Shareholding
1st Nov 20225:30 pmRNSTotal Voting Rights
14th Oct 20229:00 amRNSBoard Committee Appointment
4th Oct 20225:00 pmRNSDirector/PDMR Shareholding
4th Oct 20227:00 amRNSTrading Statement
3rd Oct 20225:00 pmRNSDirector/PDMR Shareholding
3rd Oct 20225:00 pmRNSDirector/PDMR Shareholding
3rd Oct 20225:00 pmRNSTotal Voting Rights
28th Sep 20225:00 pmRNSDirector/PDMR Shareholding
28th Sep 20225:00 pmRNSDirector/PDMR Shareholding
2nd Sep 20225:00 pmRNSDirector/PDMR Shareholding
1st Sep 20225:00 pmRNSDirector/PDMR Shareholding
1st Sep 20225:00 pmRNSTotal Voting Rights
1st Sep 20225:00 pmRNSDirector/PDMR Shareholding
10th Aug 20225:00 pmRNSDirector/PDMR Shareholding
9th Aug 20227:00 amRNSL&G Half Year Results 2022 Part 3
9th Aug 20227:00 amRNSL&G Half Year Results 2022 Part 2
9th Aug 20227:00 amRNSL&G Half Year Results 2022 Part 1
2nd Aug 20225:00 pmRNSDirector/PDMR Shareholding
1st Aug 20225:00 pmRNSDirector/PDMR Shareholding
1st Aug 20225:00 pmRNSDirector/PDMR Shareholding
1st Aug 20225:00 pmRNSTotal Voting Rights
26th Jul 20229:00 amRNSBoard Committee Appointment
7th Jul 20227:00 amRNSTrading Statement
4th Jul 20225:00 pmRNSDirector/PDMR Shareholding
1st Jul 20225:00 pmRNSDirector/PDMR Shareholding
1st Jul 20225:00 pmRNSBlock listing Interim Review
1st Jul 20225:00 pmRNSDirector/PDMR Shareholding
1st Jul 20225:00 pmRNSTotal Voting Rights
28th Jun 20227:00 amRNSHolding(s) in Company
17th Jun 20227:00 amRNSDirectorate Change
15th Jun 20225:03 pmRNSDirector/PDMR Shareholding
7th Jun 20225:00 pmRNSDirector/PDMR Shareholding
7th Jun 20225:00 pmRNSDirector/PDMR Shareholding
6th Jun 20225:06 pmRNSDirector/PDMR Shareholding
1st Jun 20225:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.